1. Home
  2. TWST vs WLY Comparison

TWST vs WLY Comparison

Compare TWST & WLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWST
  • WLY
  • Stock Information
  • Founded
  • TWST 2013
  • WLY 1807
  • Country
  • TWST United States
  • WLY United States
  • Employees
  • TWST N/A
  • WLY N/A
  • Industry
  • TWST Biotechnology: Biological Products (No Diagnostic Substances)
  • WLY Books
  • Sector
  • TWST Health Care
  • WLY Consumer Discretionary
  • Exchange
  • TWST Nasdaq
  • WLY Nasdaq
  • Market Cap
  • TWST 2.7B
  • WLY 2.7B
  • IPO Year
  • TWST 2018
  • WLY N/A
  • Fundamental
  • Price
  • TWST $42.75
  • WLY $42.38
  • Analyst Decision
  • TWST Buy
  • WLY
  • Analyst Count
  • TWST 9
  • WLY 0
  • Target Price
  • TWST $52.33
  • WLY N/A
  • AVG Volume (30 Days)
  • TWST 732.2K
  • WLY 423.1K
  • Earning Date
  • TWST 01-31-2025
  • WLY 03-06-2025
  • Dividend Yield
  • TWST N/A
  • WLY 3.36%
  • EPS Growth
  • TWST N/A
  • WLY N/A
  • EPS
  • TWST N/A
  • WLY N/A
  • Revenue
  • TWST $312,974,000.00
  • WLY $1,759,570,000.00
  • Revenue This Year
  • TWST $21.67
  • WLY N/A
  • Revenue Next Year
  • TWST $17.52
  • WLY $1.13
  • P/E Ratio
  • TWST N/A
  • WLY N/A
  • Revenue Growth
  • TWST 27.69
  • WLY N/A
  • 52 Week Low
  • TWST $27.41
  • WLY $31.87
  • 52 Week High
  • TWST $60.90
  • WLY $53.96
  • Technical
  • Relative Strength Index (RSI)
  • TWST 39.06
  • WLY 29.96
  • Support Level
  • TWST $41.06
  • WLY $41.48
  • Resistance Level
  • TWST $51.31
  • WLY $42.81
  • Average True Range (ATR)
  • TWST 2.54
  • WLY 0.91
  • MACD
  • TWST -0.61
  • WLY 0.03
  • Stochastic Oscillator
  • TWST 16.49
  • WLY 23.80

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.

About WLY John Wiley & Sons Inc.

John Wiley & Sons Inc is a provider of academic journals, books, pre- and post-hire assessments and training, test preparation materials, and online education program management solutions. The company's reportable segments are; Research, Learning, Held for Sale or Sold. The majority of the company's revenue is generated from the Research segment which provides peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. Geographically, it derives maximum revenue from the United States and the rest from the United Kingdom, China, Japan, Canada, and other countries.

Share on Social Networks: